JAMP-Cetirizine: Impurity
Last updated
Summary
Product
JAMP-Cetirizine
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
JAMP-Cetirizine |
JAMP-Cetirizine 10 mg |
DIN 02451778 |
Tablet |
Cetirizine Hydrochloride 10 mg |
MC19004C |
JAMP-Cetirizine |
JAMP-Cetirizine 20 mg |
DIN 02466171 |
Tablet |
Cetirizine Hydrochloride 20 mg |
MC20005B, MC20006 |
Issue
| The impurities are out of specification in the affected lots. |
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
|
Jamp Pharma Corporation. 1310 Nobel, Boucherville, Quebec, J4B 5H3 |
Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type II
Identification number
RA-63567
Get notified
Receive notifications for new and updated recalls and alerts by category.